Please use this identifier to cite or link to this item:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/25795Full metadata record
| ???org.dspace.app.webui.jsptag.ItemTag.dcfield??? | Value | Language |
|---|---|---|
| dc.contributor.advisor | 郭彥彬(Yen-Ping Kuo) | |
| dc.contributor.author | Ju-Yi Tsai | en |
| dc.contributor.author | 蔡儒億 | zh_TW |
| dc.date.accessioned | 2021-06-08T06:30:28Z | - |
| dc.date.copyright | 2006-08-03 | |
| dc.date.issued | 2006 | |
| dc.date.submitted | 2006-07-25 | |
| dc.identifier.citation | 阮瓊瑤：腫瘤的轉移及 Cyr61 在胃癌的研究. 國立台灣大學醫學院毒理學研究所碩士論文. 2003.
郭思堯：利用活體噬菌體顯憲法尋找口腔癌標的peptide及發展標的治療之研究. 國立台灣大學口腔生物科學研究所碩士論文. 2004. 黃穰基, 張哲壽, 周明哲, 藍中孚 : 國人頰部口腔癌與嚼檳榔關係. 中華民國口腔顎面外科學會雜誌. 1991; 3: 23. 黃湧澧, 林立民, 葛應欽 : 檳榔塊與口腔癌. 公共衛生雜誌. 1993; 19: 371-383. 黃家鼎：利用腫瘤標的性 peptide 作為台灣地區口腔癌治療之研究. 國立台灣大學口腔生物科學研究所碩士論文. 2005. 蔡崇弘，邱清華：臺灣地區口腔癌發生率研究. 中華牙誌 1990; 9: 104-115． Anand-Apte, B., B.R. Zetter, A. Viswanathan, R.G. Qiu, J. Chen, R. Ruggieri, and M. Symons. 1997. Platelet-derived growth factor and fibronectin-stimulated migration are differentially regulated by the Rac and extracellular signal-regulated kinase pathways. J Biol Chem. 272:30688-92. Babic, A.M., M.L. Kireeva, T.V. Kolesnikova, and L.F. Lau. 1998. CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci U S A. 95:6355-60. Bartholin, L., L.L. Wessner, J.M. Chirgwin, and T.A. Guise. 2006. The human Cyr61 gene is a transcriptional target of transforming growth factor beta in cancer cells. Cancer Lett. Bouvard, D., C. Brakebusch, E. Gustafsson, A. Aszodi, T. Bengtsson, A. Berna, and R. Fassler. 2001. Functional consequences of integrin gene mutations in mice. Circ Res. 89:211-23. Breuss, J.M., J. Gallo, H.M. DeLisser, I.V. Klimanskaya, H.G. Folkesson, J.F. Pittet, S.L. Nishimura, K. Aldape, D.V. Landers, W. Carpenter, and et al. 1995. Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling. J Cell Sci. 108 ( Pt 6):2241-51. Brigstock, D.R. 1999. The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr Rev. 20:189-206. Brigstock, D.R., R. Goldschmeding, K.I. Katsube, S.C. Lam, L.F. Lau, K. Lyons, C. Naus, B. Perbal, B. Riser, M. Takigawa, and H. Yeger. 2003. Proposal for a unified CCN nomenclature. Mol Pathol. 56:127-8. Brunner, A., J. Chinn, M. Neubauer, and A.F. Purchio. 1991. Identification of a gene family regulated by transforming growth factor-beta. DNA Cell Biol. 10:293-300. Cance, W.G., J.E. Harris, M.V. Iacocca, E. Roche, X. Yang, J. Chang, S. Simkins, and L. Xu. 2000. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin Cancer Res. 6:2417-23. Chen, C.C., N. Chen, and L.F. Lau. 2001a. The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts. J Biol Chem. 276:10443-52. Chen, C.C., F.E. Mo, and L.F. Lau. 2001b. The angiogenic factor Cyr61 activates a genetic program for wound healing in human skin fibroblasts. J Biol Chem. 276:47329-37. Chen, N., C.C. Chen, and L.F. Lau. 2000. Adhesion of human skin fibroblasts to Cyr61 is mediated through integrin alpha 6beta 1 and cell surface heparan sulfate proteoglycans. J Biol Chem. 275:24953-61. Chung, K.C., and Y.S. Ahn. 1998. Expression of immediate early gene cyr61 during the differentiation of immortalized embryonic hippocampal neuronal cells. Neurosci Lett. 255:155-8. De Arcangelis, A., and E. Georges-Labouesse. 2000. Integrin and ECM functions: roles in vertebrate development. Trends Genet. 16:389-95. Desnoyers, L. 2004. Structural basis and therapeutic implication of the interaction of CCN proteins with glycoconjugates. Curr Pharm Des. 10:3913-28. Dvorak, H.F. 1986. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 315:1650-9. Folkman, J. 1995. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med. 333:1757-63. Gery, S., D. Xie, D. Yin, H. Gabra, C. Miller, H. Wang, D. Scott, W.S. Yi, M.L. Popoviciu, J.W. Said, and H.P. Koeffler. 2005. Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells. Clin Cancer Res. 11:7243-54. Grzeszkiewicz, T.M., D.J. Kirschling, N. Chen, and L.F. Lau. 2001. CYR61 stimulates human skin fibroblast migration through Integrin alpha vbeta 5 and enhances mitogenesis through integrin alpha vbeta 3, independent of its carboxyl-terminal domain. J Biol Chem. 276:21943-50. Gupta, S., T. Barrett, A.J. Whitmarsh, J. Cavanagh, H.K. Sluss, B. Derijard, and R.J. Davis. 1996. Selective interaction of JNK protein kinase isoforms with transcription factors. Embo J. 15:2760-70. Hamidi, S., T. Salo, T. Kainulainen, J. Epstein, K. Lerner, and H. Larjava. 2000. Expression of alpha(v)beta6 integrin in oral leukoplakia. Br J Cancer. 82:1433-40. Hanks, S.K., L. Ryzhova, N.Y. Shin, and J. Brabek. 2003. Focal adhesion kinase signaling activities and their implications in the control of cell survival and motility. Front Biosci. 8:d982-96. Haskell, H., M. Natarajan, T.P. Hecker, Q. Ding, J. Stewart, Jr., J.R. Grammer, and C.L. Gladson. 2003. Focal adhesion kinase is expressed in the angiogenic blood vessels of malignant astrocytic tumors in vivo and promotes capillary tube formation of brain microvascular endothelial cells. Clin Cancer Res. 9:2157-65. Hauck, C.R., D.A. Hsia, D. Ilic, and D.D. Schlaepfer. 2002a. v-Src SH3-enhanced interaction with focal adhesion kinase at beta 1 integrin-containing invadopodia promotes cell invasion. J Biol Chem. 277:12487-90. Hauck, C.R., D.A. Hsia, X.S. Puente, D.A. Cheresh, and D.D. Schlaepfer. 2002b. FRNK blocks v-Src-stimulated invasion and experimental metastases without effects on cell motility or growth. Embo J. 21:6289-302. Hauck, C.R., D.A. Hsia, and D.D. Schlaepfer. 2002c. The focal adhesion kinase--a regulator of cell migration and invasion. IUBMB Life. 53:115-9. Holloway, S.E., A.W. Beck, L. Girard, M.R. Jaber, C.C. Barnett, Jr., R.A. Brekken, and J.B. Fleming. 2005. Increased expression of Cyr61 (CCN1) identified in peritoneal metastases from human pancreatic cancer. J Am Coll Surg. 200:371-7. Hood, J.D., and D.A. Cheresh. 2002. Role of integrins in cell invasion and migration. Nat Rev Cancer. 2:91-100. Hsia, D.A., S.K. Mitra, C.R. Hauck, D.N. Streblow, J.A. Nelson, D. Ilic, S. Huang, E. Li, G.R. Nemerow, J. Leng, K.S. Spencer, D.A. Cheresh, and D.D. Schlaepfer. 2003. Differential regulation of cell motility and invasion by FAK. J Cell Biol. 160:753-67. Huang, C., Z. Rajfur, C. Borchers, M.D. Schaller, and K. Jacobson. 2003. JNK phosphorylates paxillin and regulates cell migration. Nature. 424:219-23. Huang, X., J. Wu, S. Spong, and D. Sheppard. 1998. The integrin alphavbeta6 is critical for keratinocyte migration on both its known ligand, fibronectin, and on vitronectin. J Cell Sci. 111 ( Pt 15):2189-95. Hynes, R.O. 1992. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 69:11-25. Hynes, R.O. 2002. A reevaluation of integrins as regulators of angiogenesis. Nat Med. 8:918-21. Ilic, D., Y. Furuta, S. Kanazawa, N. Takeda, K. Sobue, N. Nakatsuji, S. Nomura, J. Fujimoto, M. Okada, and T. Yamamoto. 1995. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature. 377:539-44. Ilic, D., B. Kovacic, S. McDonagh, F. Jin, C. Baumbusch, D.G. Gardner, and C.H. Damsky. 2003. Focal adhesion kinase is required for blood vessel morphogenesis. Circ Res. 92:300-7. Janes, S.M., and F.M. Watt. 2004. Switch from alphavbeta5 to alphavbeta6 integrin expression protects squamous cell carcinomas from anoikis. J Cell Biol. 166:419-31. Javelaud, D., J. Laboureau, E. Gabison, F. Verrecchia, and A. Mauviel. 2003. Disruption of basal JNK activity differentially affects key fibroblast functions important for wound healing. J Biol Chem. 278:24624-8. Jay, P., J.L. Berge-Lefranc, C. Marsollier, C. Mejean, S. Taviaux, and P. Berta. 1997. The human growth factor-inducible immediate early gene, CYR61, maps to chromosome 1p. Oncogene. 14:1753-7. Jones, J., F.M. Watt, and P.M. Speight. 1997. Changes in the expression of alpha v integrins in oral squamous cell carcinomas. J Oral Pathol Med. 26:63-8. Kavurma, M.M., and L.M. Khachigian. 2003. ERK, JNK, and p38 MAP kinases differentially regulate proliferation and migration of phenotypically distinct smooth muscle cell subtypes. J Cell Biochem. 89:289-300. Kawauchi, T., K. Chihama, Y. Nabeshima, and M. Hoshino. 2003. The in vivo roles of STEF/Tiam1, Rac1 and JNK in cortical neuronal migration. Embo J. 22:4190-201. Kireeva, M.L., S.C. Lam, and L.F. Lau. 1998. Adhesion of human umbilical vein endothelial cells to the immediate-early gene product Cyr61 is mediated through integrin alphavbeta3. J Biol Chem. 273:3090-6. Kireeva, M.L., F.E. Mo, G.P. Yang, and L.F. Lau. 1996. Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion. Mol Cell Biol. 16:1326-34. Klemke, R.L., S. Cai, A.L. Giannini, P.J. Gallagher, P. de Lanerolle, and D.A. Cheresh. 1997. Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol. 137:481-92. Ko, Y.C., Y.L. Huang, C.H. Lee, M.J. Chen, L.M. Lin, and C.C. Tsai. 1995. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med. 24:450-3. Kolesnikova, T.V., and L.F. Lau. 1998. Human CYR61-mediated enhancement of bFGF-induced DNA synthesis in human umbilical vein endothelial cells. Oncogene. 16:747-54. Kumamoto, H., and K. Ooya. 1999. Expression of E-cadherin and alpha-catenin in epithelial odontogenic tumors: an immunohistochemical study. J Oral Pathol Med. 28:152-7. Latinkic, B.V., T.P. O'Brien, and L.F. Lau. 1991. Promoter function and structure of the growth factor-inducible immediate early gene cyr61. Nucleic Acids Res. 19:3261-7. Leu, S.J., S.C. Lam, and L.F. Lau. 2002. Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins alphavbeta3 and alpha6beta1 in human umbilical vein endothelial cells. J Biol Chem. 277:46248-55. Leu, S.J., Y. Liu, N. Chen, C.C. Chen, S.C. Lam, and L.F. Lau. 2003. Identification of a novel integrin alpha 6 beta 1 binding site in the angiogenic inducer CCN1 (CYR61). J Biol Chem. 278:33801-8. Lim, Y., I. Han, J. Jeon, H. Park, Y.Y. Bahk, and E.S. Oh. 2004. Phosphorylation of focal adhesion kinase at tyrosine 861 is crucial for Ras transformation of fibroblasts. J Biol Chem. 279:29060-5. Lin, C.G., C.C. Chen, S.J. Leu, T.M. Grzeszkiewicz, and L.F. Lau. 2005a. Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing. J Biol Chem. 280:8229-37. Lin, C.G., S.J. Leu, N. Chen, C.M. Tebeau, S.X. Lin, C.Y. Yeung, and L.F. Lau. 2003. CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family. J Biol Chem. 278:24200-8. Lin, M.T., C.Y. Zuon, C.C. Chang, S.T. Chen, C.P. Chen, B.R. Lin, M.Y. Wang, Y.M. Jeng, K.J. Chang, P.H. Lee, W.J. Chen, and M.L. Kuo. 2005b. Cyr61 induces gastric cancer cell motility/invasion via activation of the integrin/nuclear factor-kappaB/cyclooxygenase-2 signaling pathway. Clin Cancer Res. 11:5809-20. Liu, S., D.A. Calderwood, and M.H. Ginsberg. 2000. Integrin cytoplasmic domain-binding proteins. J Cell Sci. 113 ( Pt 20):3563-71. Mandal, S.K., L.V. Rao, T.T. Tran, and U.R. Pendurthi. 2005. A novel mechanism of plasmin-induced mitogenesis in fibroblasts. J Thromb Haemost. 3:163-9. Menendez, J.A., L. Vellon, I. Mehmi, P.K. Teng, D.W. Griggs, and R. Lupu. 2005. A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway. Oncogene. 24:761-79. Minden, A., A. Lin, F.X. Claret, A. Abo, and M. Karin. 1995. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell. 81:1147-57. Mitra, S.K., D.A. Hanson, and D.D. Schlaepfer. 2005. Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol. 6:56-68. Mo, F.E., A.G. Muntean, C.C. Chen, D.B. Stolz, S.C. Watkins, and L.F. Lau. 2002. CYR61 (CCN1) is essential for placental development and vascular integrity. Mol Cell Biol. 22:8709-20. Nguyen, D.H., D.J. Webb, A.D. Catling, Q. Song, A. Dhakephalkar, M.J. Weber, K.S. Ravichandran, and S.L. Gonias. 2000. Urokinase-type plasminogen activator stimulates the Ras/Extracellular signal-regulated kinase (ERK) signaling pathway and MCF-7 cell migration by a mechanism that requires focal adhesion kinase, Src, and Shc. Rapid dissociation of GRB2/Sps-Shc complex is associated with the transient phosphorylation of ERK in urokinase-treated cells. J Biol Chem. 275:19382-8. Nguyen, N., A. Kuliopulos, R.A. Graham, and L. Covic. 2006. Tumor-derived Cyr61(CCN1) promotes stromal matrix metalloproteinase-1 production and protease-activated receptor 1-dependent migration of breast cancer cells. Cancer Res. 66:2658-65. O'Brien, T.P., and L.F. Lau. 1992. Expression of the growth factor-inducible immediate early gene cyr61 correlates with chondrogenesis during mouse embryonic development. Cell Growth Differ. 3:645-54. O'Brien, T.P., G.P. Yang, L. Sanders, and L.F. Lau. 1990. Expression of cyr61, a growth factor-inducible immediate-early gene. Mol Cell Biol. 10:3569-77. Owens, D.M., M.R. Romero, C. Gardner, and F.M. Watt. 2003. Suprabasal alpha6beta4 integrin expression in epidermis results in enhanced tumourigenesis and disruption of TGFbeta signalling. J Cell Sci. 116:3783-91. Parsons, J.T. 2003. Focal adhesion kinase: the first ten years. J Cell Sci. 116:1409-16. Perbal, B. 2001a. NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues. Mol Pathol. 54:57-79. Perbal, B. 2001b. The CCN family of genes: a brief history. Mol Pathol. 54:103-4. Perbal, B. 2004. CCN proteins: multifunctional signalling regulators. Lancet. 363:62-4. Regezi, J.A., D.M. Ramos, R. Pytela, N.P. Dekker, and R.C. Jordan. 2002. Tenascin and beta 6 integrin are overexpressed in floor of mouth in situ carcinomas and invasive squamous cell carcinomas. Oral Oncol. 38:332-6. Ren, X.D., W.B. Kiosses, D.J. Sieg, C.A. Otey, D.D. Schlaepfer, and M.A. Schwartz. 2000. Focal adhesion kinase suppresses Rho activity to promote focal adhesion turnover. J Cell Sci. 113 ( Pt 20):3673-8. Rhoads, J.M., X. Niu, J. Odle, and L.M. Graves. 2006. ROLE OF mTOR SIGNALING IN INTESTINAL CELL MIGRATION. Am J Physiol Gastrointest Liver Physiol. Sakakibara, K., B. Liu, S. Hollenbeck, and K.C. Kent. 2005. Rapamycin inhibits fibronectin-induced migration of the human arterial smooth muscle line (E47) through the mammalian target of rapamycin. Am J Physiol Heart Circ Physiol. 288:H2861-8. Sampath, D., R.C. Winneker, and Z. Zhang. 2001. Cyr61, a member of the CCN family, is required for MCF-7 cell proliferation: regulation by 17beta-estradiol and overexpression in human breast cancer. Endocrinology. 142:2540-8. Sarbassov, D.D., D.A. Guertin, S.M. Ali, and D.M. Sabatini. 2005. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science. 307:1098-101.Schaller, M.D. 2001. Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochim Biophys Acta. 1540:1-21. Schlaepfer, D.D., S.K. Mitra, and D. Ilic. 2004. Control of motile and invasive cell phenotypes by focal adhesion kinase. Biochim Biophys Acta. 1692:77-102. Schober, J.M., L.F. Lau, T.P. Ugarova, and S.C. Lam. 2003. Identification of a novel integrin alphaMbeta2 binding site in CCN1 (CYR61), a matricellular protein expressed in healing wounds and atherosclerotic lesions. J Biol Chem. 278:25808-15. Sheppard, D. 2000. In vivo functions of integrins: lessons from null mutations in mice. Matrix Biol. 19:203-9. Song, K., H. Wang, T.L. Krebs, and D. Danielpour. 2006. Novel roles of Akt and mTOR in suppressing TGF-beta/ALK5-mediated Smad3 activation. Embo J. 25:58-69. Thomas, G.J., M.L. Nystrom, and J.F. Marshall. 2006. Alphavbeta6 integrin in wound healing and cancer of the oral cavity. J Oral Pathol Med. 35:1-10. Thomas, G.J., S. Poomsawat, M.P. Lewis, I.R. Hart, P.M. Speight, and J.F. Marshall. 2001. alpha v beta 6 Integrin upregulates matrix metalloproteinase 9 and promotes migration of normal oral keratinocytes. J Invest Dermatol. 116:898-904. Todorovicc, V., C.C. Chen, N. Hay, and L.F. Lau. 2005. The matrix protein CCN1 (CYR61) induces apoptosis in fibroblasts. J Cell Biol. 171:559-68. Tong, X., J. O'Kelly, D. Xie, A. Mori, N. Lemp, R. McKenna, C.W. Miller, and H.P. Koeffler. 2004. Cyr61 suppresses the growth of non-small-cell lung cancer cells via the beta-catenin-c-myc-p53 pathway. Oncogene. 23:4847-55. Tong, X., D. Xie, J. O'Kelly, C.W. Miller, C. Muller-Tidow, and H.P. Koeffler. 2001. Cyr61, a member of CCN family, is a tumor suppressor in non-small cell lung cancer. J Biol Chem. 276:47709-14. Toutant, M., A. Costa, J.M. Studler, G. Kadare, M. Carnaud, and J.A. Girault. 2002. Alternative splicing controls the mechanisms of FAK autophosphorylation. Mol Cell Biol. 22:7731-43. Tsai, M.S., A.E. Hornby, J. Lakins, and R. Lupu. 2000. Expression and function of CYR61, an angiogenic factor, in breast cancer cell lines and tumor biopsies. Cancer Res. 60:5603-7. Vellon, L., J.A. Menendez, and R. Lupu. 2005. AlphaVbeta3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer. Oncogene. 24:3759-73. Walker, T.M., P.R. Van Ginkel, R.L. Gee, H. Ahmadi, L. Subramanian, B.R. Ksander, L.F. Meisner, D.M. Albert, and A.S. Polans. 2002. Expression of angiogenic factors Cyr61 and tissue factor in uveal melanoma. Arch Ophthalmol. 120:1719-25. Watt, F.M. 2002. Role of integrins in regulating epidermal adhesion, growth and differentiation. Embo J. 21:3919-26. Webb, D.J., D.H. Nguyen, and S.L. Gonias. 2000. Extracellular signal-regulated kinase functions in the urokinase receptor-dependent pathway by which neutralization of low density lipoprotein receptor-related protein promotes fibrosarcoma cell migration and matrigel invasion. J Cell Sci. 113 ( Pt 1):123-34. wSalazar, E.P., I. Hunger-Glaser, and E. Rozengurt. 2003. Dissociation of focal adhesion kinase and paxillin tyrosine phosphorylation induced by bombesin and lysophosphatidic acid from epidermal growth factor receptor transactivation in Swiss 3T3 cells. J Cell Physiol. 194:314-24. Xie, D., D. Yin, X. Tong, J. O'Kelly, A. Mori, C. Miller, K. Black, D. Gui, J.W. Said, and H.P. Koeffler. 2004a. Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways. Cancer Res. 64:1987-96. Xie, D., D. Yin, H.J. Wang, G.T. Liu, R. Elashoff, K. Black, and H.P. Koeffler. 2004b. Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas. Clin Cancer Res. 10:2072-81. Xie, H., M.A. Pallero, K. Gupta, P. Chang, M.F. Ware, W. Witke, D.J. Kwiatkowski, D.A. Lauffenburger, J.E. Murphy-Ullrich, and A. Wells. 1998. EGF receptor regulation of cell motility: EGF induces disassembly of focal adhesions independently of the motility-associated PLCgamma signaling pathway. J Cell Sci. 111 ( Pt 5):615-24. Yamauchi, J., J.R. Chan, Y. Miyamoto, G. Tsujimoto, and E.M. Shooter. 2005. The neurotrophin-3 receptor TrkC directly phosphorylates and activates the nucleotide exchange factor Dbs to enhance Schwann cell migration. Proc Natl Acad Sci U S A. 102:5198-203. Yamauchi, J., J.R. Chan, and E.M. Shooter. 2003. Neurotrophin 3 activation of TrkC induces Schwann cell migration through the c-Jun N-terminal kinase pathway. Proc Natl Acad Sci U S A. 100:14421-6. Yang, G.P., and L.F. Lau. 1991. Cyr61, product of a growth factor-inducible immediate early gene, is associated with the extracellular matrix and the cell surface. Cell Growth Differ. 2:351-7. Zeng, Z.J., L.Y. Yang, X. Ding, and W. Wang. 2004. Expressions of cysteine-rich61, connective tissue growth factor and Nov genes in hepatocellular carcinoma and their clinical significance. World J Gastroenterol. 10:3414-8. Zhang, L., W. Wang, Y. Hayashi, J.V. Jester, D.E. Birk, M. Gao, C.Y. Liu, W.W. Kao, M. Karin, and Y. Xia. 2003. A role for MEK kinase 1 in TGF-beta/activin-induced epithelium movement and embryonic eyelid closure. Embo J. 22:4443-54. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/25795 | - |
| dc.description.abstract | 中文摘要
Cyr61是一種分泌型蛋白，為 CCN family中第一個被發現的成員，當其由細胞分泌出去後即表現於細胞表面與細胞基質之間。Cyr61可作為細胞表面接受器 Integrin 的配體，其功用可調節細胞的附著、移動、增生、分化及參與血管新生，在許多癌症中被指出與 tumorgenesis 有關。 在臺灣， 衛生署 92 年癌症登記報告指出，口腔癌在臺灣男性十大癌症中標準化死亡率為第三位。 此外，口腔癌年增率達 14.42% 是臺灣地區年增率最高之癌症。因此我們有必要了解臺灣的口腔癌分子致癌機轉。較早之前的實驗室研究中指出，口腔癌病人癌化組織中 Cyr61 蛋白表現明顯較正常組織高，但是 Cyr61 在口腔癌的角色至今仍不明確。有鑑於此，本研究擬探討 Cyr61 在口腔癌進展過程所扮演的角色。我們將 Cyr61 轉殖到 Cyr61 表現量較低的 Ca9-22 細胞中，以 pcDNA3 當作 vector 控制組 （Ca9-22/Neo），獲得 Cyr61 蛋白表現量高於控制組的兩個細胞株 Ca9-22/Cyr61#1 和 Ca9-22/Cyr61#2。比較其生長速率、移動能力、及促血管新生能力的改變，結果發現大量表現 Cyr61 的兩個細胞株其生長速率較快、移動能力比對照組增加 10.7nm/hr。轉植（transplant） Cyr61 表現株細胞到嚴重複合免疫不全症（ NOD-SCID mice ）小鼠，結果 Cyr61 過量表現細胞株可增加腫瘤的整體體積約 2.5 倍且從外觀以及病理切片可發現較高密度的血管新生跡象。 根據前人研究指出 Cyr61 促進移動能力的機轉可藉由活化 Integrin /NF-kB/COX2 使胃癌細胞AGS移動能力增加。在乳癌( MCF7 )中 Cyr61 促進 stromal cell 分泌 Matrix metalloproteinase-1（MMP1）進而活化癌細胞上的 Protease-activated receptor-1（PAR1）使乳癌細胞增加移動力。然而在本研究發現口腔癌中 Cyr61 增加細胞移動的路徑不同於其他癌症，其影響路徑為：分泌到細胞外面的 Cyr61 藉由自體結合( autocrine ) 或異體結合 ( paracrine ) 和avb3 Integrin 結合，在前人研究的結果中藉由此訊息傳遞路徑產生自體迴路，分別使得 av 及 b3 在蛋白質層面也能增加；但在本實驗所得結果 Cyr61 則是增加 avb3 在細胞上的親和力而單獨的蛋白質在量上無明顯差異。Cyr61 和 Integrin 的結合使得 FAK 的 Y-397 被磷酸化再將訊息傳給 PI3K/Akt 以及 JNK 最終使細胞骨架改變協助細胞的移動。而此途徑可外加 LM609 ( avb3 functional blocking antibody ) 、 LY294002 ( PI3K inhibitor ) 以及 JNK inhibitor II 予以抑制。 本篇結果首次證實 Cyr61 在口腔癌中為促進癌化因子，對於細胞增生、移動能力、腫瘤形成以及血管新生皆有顯著的影響；其中影響細胞移動的機制為 Cyr61/avb3 – FAK - PI3K/Akt/ JNK 和目前在其他癌症所發現的路徑不同。因此，可藉由抑制訊息傳遞路徑的成員來阻斷 Cyr61 對口腔癌細胞的移動能力以冀望在未來可作為新興藥物開發之策略。 | zh_TW |
| dc.description.abstract | Abstract
Cyr61 is one of members of CCN family; these proteins are secreted proteins act as ligands between cell surface and extracellular matrix. When ligand-receptor complex formation, Cyr61 could regulate cell adhesion, migration, proliferation, differentiation and angiogenesis. The incidence of oral cancer in Taiwan has being more and more serious but we still cannot cure it. Our laboratory found Cyr61 had high expression levels in patients but we did not know the function of Cyr61 in oral carcinogenesis. So we established the Cyr61-overexpressed stable clones in Ca9-22, which had lower Cyr61 expression. Clones were named Cyr61#1 and Cyr61#2, the other hand used pcDNA3 as vector control was named Neo. Cyr61-expressed clones could promote cell proliferation, in vivo tumor formation in NOD-SCID mice, angiogenesis and migration. It was the first time we identified Cyr61 is an oncogene in oral cancer. The mechanism of Cyr61-induced cell migration is different from others, in our study Cyr61 increase its receptor avb3 integrin expression on cell membrane, and then activate this heterodimer to recruitment of FAK. Recruited FAK is autophosphorylated at Tyr-397, active FAK phosphorylate PI3K-Akt Ser473 and JNK Thr183/Tyr185, respectively to increase the cell migration. This effect could recover by treatment of LM 609, avb3 integrin functional blocking antibody, PI3K inhibitor: LY294002, Wortmannin and JNK inhibitor: JNK inhibitor II. These results suggest that interrupting the communication of Cyr61-induced signaling may provide an alternative therapeutic approach for the treatment of oral cancer. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-08T06:30:28Z (GMT). No. of bitstreams: 1 ntu-95-R93450013-1.pdf: 10086176 bytes, checksum: 6bd941cdc4686e05f862a7c02a2a977a (MD5) Previous issue date: 2006 | en |
| dc.description.tableofcontents | 中文摘要…………………………………………………………………………1
英文摘要（Abstract）…………………………………………………………3 導論（Introduction）…………………………………………………………..4 第一節 口腔癌的病理與流行病學………………………………………..4 第二節 Cyr61………………………………………………………………7 第三節 Integrin……………………………………………………………13 第四節 Focal adhesion kinase……………………………………………..16 第五節 研究動機………………………………………………………….19 材料方法（Material and Method）…………………………………………..20 結果（Result） 口腔癌病理切片含有高量 Cyr61 蛋白質的表現………………………..31 建立 Cyr61 持續表現細胞株……………………………………………..31 Cyr61 可促進口腔癌細胞 Ca9-22 的生長速率………………………….32 Cyr61 可促進口腔癌細胞在小鼠體內形成腫瘤………………………...32 Cyr61 可促進細胞的移動能力…………………………………………...33 Cyr61 可使細胞受器 | |
| dc.language.iso | zh-TW | |
| dc.title | Cyr61 在口腔癌細胞移動中所扮演的角色及其機轉 | zh_TW |
| dc.title | The of Cyr61 in oral cancer migration | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 94-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 郭明良(Min-Liang Kuo),蕭宏昇 | |
| dc.subject.keyword | 口腔癌,細胞移動,血管新生,細胞增生, | zh_TW |
| dc.subject.keyword | oral cancer,cell migration,angiogenesis,proliferation,Cyr61,FAK,integrin,Akt,JNK, | en |
| dc.relation.page | 93 | |
| dc.rights.note | 未授權 | |
| dc.date.accepted | 2006-07-26 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 口腔生物科學研究所 | zh_TW |
| Appears in Collections: | 口腔生物科學研究所 | |
Files in This Item:
| File | Size | Format | |
|---|---|---|---|
| ntu-95-1.pdf Restricted Access | 9.85 MB | Adobe PDF |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.